Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • The share is getting closer to its long-term support in weekly data, at EUR 38.99, which offers good timing for buyers.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
  • Technically, the stock approaches a strong medium-term resistance at EUR 45.92.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart
Sector Hospitals, Clinics & Primary Care Services
1st jan.Capitalisation (M$)Investor Rating
FRESENIUS SE & CO. KGAA3.95%27 319
AIER EYE HOSPITAL GROUP CO ..--.--%14 662
BANGKOK DUSIT MEDICAL SERVI..--.--%12 156
IHH HEALTHCARE BHD--.--%11 898
RAMSAY HEALTH CARE LIMITED20.73%9 330
HAPVIDA PARTICIPACOES E INV..60.19%8 594
NOTRE DAME INTERMEDICA PART..72.80%6 464
-
TOPCHOICE MEDICAL CORPORATI..96.21%4 429
MEDICLINIC INTERNATIONAL-1.18%2 883
APOLLO HOSPITALS ENTERPRISE..15.32%2 798
THE ENSIGN GROUP, INC.30.27%2 692
AMN HEALTHCARE SERVICES, IN..-1.64%2 600
MOUWASAT MEDICAL SERVICES C..--.--%2 395
MITRA KELUARGA KARYASEHAT T..--.--%2 346
PREMIER INC-1.15%2 335
U.S. PHYSICAL THERAPY, INC.31.27%1 682
More Results
Financials (EUR)
Sales 2019 35 505 M
EBIT 2019 4 666 M
Net income 2019 1 836 M
Debt 2019 20 580 M
Yield 2019 1,81%
P/E ratio 2019 13,3x
P/E ratio 2020 12,2x
EV / Sales2019 1,27x
EV / Sales2020 1,13x
Capitalization 24 524 M
Upcoming event on FRESENIUS SE & CO. KGAA
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes